(VIANEWS) – Blackrock Core Bond Trust Blackrock Core Bond Trust (BHK), Pimco California Municipal Income Fund II (PCK), Cardinal Health (CAH) are the highest dividend yield stocks on this list.

Rank Financial Asset Price Change Forward Dividend Yield Updated (EST)
1 Blackrock Core Bond Trust Blackrock Core Bond Trust (BHK) 16.35 0.12% 5.48% 2021-07-29 06:14:28
2 Pimco California Municipal Income Fund II (PCK) 9.59 0.74% 4% 2021-07-30 06:09:06
3 Cardinal Health (CAH) 59.38 -1.02% 3.3% 2021-07-30 15:38:03
4 Civista Bancshares (CIVB) 23.41 0.26% 2.4% 2021-07-27 15:10:13
5 Astrazeneca (AZN) 57.24 -0.69% 2.34% 2021-07-30 15:37:16

Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. Blackrock Core Bond Trust Blackrock Core Bond Trust (BHK) – Dividend Yield: 5.48%

BlackRock Core Bond Trust is a closed-ended fixed income mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the fixed income markets of the United States. The fund primarily invests in investment grade quality bonds, including corporate bonds, government and agency securities, and mortgage-related securities. BlackRock Core Bond Trust was formed on November 30, 2001 and is domiciled in the United States.

Volume

Today’s last reported volume for Blackrock Core Bond Trust Blackrock Core Bond Trust is 59059, 51.3% below its average volume of 121260.

Blackrock Core Bond Trust Blackrock Core Bond Trust’s last close was $16.35, 3.54% under its 52-week high of $16.95.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Blackrock Core Bond Trust Blackrock Core Bond Trust’s stock is considered to be oversold (<=20).

Blackrock Core Bond Trust Blackrock Core Bond Trust’s Stock Yearly Top and Bottom Value

Blackrock Core Bond Trust Blackrock Core Bond Trust’s stock is valued at $16.35 at 10:15 EST, under its 52-week high of $16.95 and higher than its 52-week low of $14.97.

Blackrock Core Bond Trust Blackrock Core Bond Trust’s Moving Average

Blackrock Core Bond Trust Blackrock Core Bond Trust’s value is higher than its 50-day moving average of $16.34 and above its 200-day moving average of $15.96.

More news about Blackrock Core Bond Trust Blackrock Core Bond Trust.

2. Pimco California Municipal Income Fund II (PCK) – Dividend Yield: 4%

PIMCO California Municipal Income Fund II is a closed ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. It is co-managed by Pacific Investment Management Company LLC. The fund invests in fixed income markets of United States. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in municipal fixed-income securities. Its portfolio of investments include investments in California municipal bonds and notes, other municipal bonds and notes, call and put options written, California variable rate notes, other variable rate notes, corporate notes, California variable rate demand note, and U.S. treasury bills. PIMCO California Municipal Income Fund II was formed in June 28, 2002 and is domiciled in United States.

Volume

Today’s last reported volume for Pimco California Municipal Income Fund II is 26430, 40.92% below its average volume of 44737.

Pimco California Municipal Income Fund II’s last close was $9.59, 1.74% below its 52-week high of $9.76.

Pimco California Municipal Income Fund II’s Revenue

Year-on-year quarterly revenue growth declined by 16.3%, now sitting on 17.94M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pimco California Municipal Income Fund II’s stock is considered to be oversold (<=20).

Pimco California Municipal Income Fund II’s Stock Yearly Top and Bottom Value

Pimco California Municipal Income Fund II’s stock is valued at $9.59 at 10:15 EST, under its 52-week high of $9.76 and way higher than its 52-week low of $8.51.

Pimco California Municipal Income Fund II’s Moving Average

Pimco California Municipal Income Fund II’s worth is higher than its 50-day moving average of $9.57 and above its 200-day moving average of $9.20.

More news about Pimco California Municipal Income Fund II.

3. Cardinal Health (CAH) – Dividend Yield: 3.3%

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company operates through two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. It also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; and offers pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers. In addition, this segment repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products. It also provides incontinence, nutritional delivery, wound care, cardiovascular, and endovascular products; single-use surgical drapes, gowns and apparel, and fluid suction and collection systems; urology products; operating room supplies; and electrode products. In addition, this segment distributes a range of national brand products, including medical, surgical, and laboratory products; and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

Volume

Today’s last reported volume for Cardinal Health is 4440490, 88.64% above its average volume of 2353960.

Cardinal Health’s last close was $59.99, 4.72% below its 52-week high of $62.96.

The company’s growth estimates for the current quarter is 15.4% and a drop 4.6% for the next.

Cardinal Health’s Revenue

Year-on-year quarterly revenue growth grew by 0.3%, now sitting on 156.57B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Cardinal Health’s stock is considered to be oversold (<=20).

Cardinal Health’s Stock Yearly Top and Bottom Value

Cardinal Health’s stock is valued at $59.38 at 10:15 EST, under its 52-week high of $62.96 and way above its 52-week low of $44.65.

Cardinal Health’s Moving Average

Cardinal Health’s worth is above its 50-day moving average of $57.62 and higher than its 200-day moving average of $57.04.

More news about Cardinal Health.

4. Civista Bancshares (CIVB) – Dividend Yield: 2.4%

Civista Bancshares, Inc. operates as the financial holding company for Civista Bank that provides community banking services. The company collects a range of customer deposits; and offers commercial, commercial and residential real estate mortgage, real estate construction, and consumer loans, as well as letters of credit. It also purchases securities; and provides trust and third party insurance services. The company operates branch banking offices in Ohio communities, including Sandusky, Norwalk, Berlin Heights, Huron, Port Clinton, Castalia, New Washington, Shelby, Willard, Greenwich, Plymouth, Shiloh, Akron, Dublin, Plain City, Urbana, Russells Point, West Liberty, Quincy, Dayton, and Beachwood; and Indiana communities comprising Lawrenceburg, Aurora, West Harrison, Milan, Osgood, and Versailles. It also operates loan production offices in Westlake, Ohio; and Fort Mitchell, Kentucky. The company was formerly known as First Citizens Banc Corp and changed its name to Civista Bancshares, Inc. in May 2015. Civista Bancshares, Inc. was founded in 1884 and is headquartered in Sandusky, Ohio.

Volume

Today’s last reported volume for Civista Bancshares is 52108, 1.22% below its average volume of 52749.

Civista Bancshares ‘s last close was $23.35, 2.63% below its 52-week high of $23.98.

The company’s growth estimates for the current quarter and the next is 39% and 8.3%, respectively.

Civista Bancshares ‘s Revenue

Year-on-year quarterly revenue growth grew by 29.2%, now sitting on 120.54M for the twelve trailing months.

Civista Bancshares ‘s Stock Yearly Top and Bottom Value

Civista Bancshares ‘s stock is valued at $23.41 at 10:15 EST, below its 52-week high of $23.98 and way higher than its 52-week low of $11.25.

Civista Bancshares ‘s Moving Average

Civista Bancshares ‘s value is above its 50-day moving average of $22.72 and above its 200-day moving average of $21.83.

More news about Civista Bancshares .

5. Astrazeneca (AZN) – Dividend Yield: 2.34%

AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR/Komboglyze, Onglyza, Qtern, Symlin, Xigduo/Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Tudorza/Eklira, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalen and Synagis for infection diseases; Movantik/Moventig, Seroquel IR/Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.

Volume

Today’s last reported volume for Astrazeneca is 7065560, 34.58% below its average volume of 10799800.

Astrazeneca’s last close was $57.64, 5.4% under its 52-week high of $60.93.

Astrazeneca’s Sales

Astrazeneca’s sales growth is 17% for the present quarter and 27.3% for the next.

Astrazeneca’s Revenue

Year-on-year quarterly revenue growth grew by 15.2%, now sitting on 27.58B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Astrazeneca’s stock is considered to be oversold (<=20).

Astrazeneca’s Stock Yearly Top and Bottom Value

Astrazeneca’s stock is valued at $57.24 at 10:15 EST, below its 52-week high of $60.93 and way higher than its 52-week low of $46.48.

Astrazeneca’s Moving Average

Astrazeneca’s value is below its 50-day moving average of $58.70 and above its 200-day moving average of $53.49.

More news about Astrazeneca.

LEAVE A REPLY

Please enter your comment!
Please enter your name here